Hypercalcemic encephalopathy in a patient on anti-TB treatment for glandular tuberculosis
Abraham, G.; Sadasivam, P.B.; Gaspar, J.H.; Isphani, N.; Lawrence, R.
Journal of the Association of Physicians of India 40(8): 539-540
1992
ISSN/ISBN: 0004-5772 PMID: 1308493 Document Number: 391865
An 84 years old male patient presented with hypercalcemic encephalopathy and mild azotemia while on anti-tuberculous treatment for glandular tuberculosis. He recovered fully during treatment with hydration, intravenous frusemide and oral prednisolone while continuing on the antituberculous therapy.
Document emailed within 1 workday
Related Documents
Thewjitcharoen, Y.; Lumlertgul, N. 2012: Painless thyroiditis complicating with hypercalcemic encephalopathy Journal of the Medical Association of Thailand 95(1): 119-123Cornette, M.; Grisar, T. 1977: A study of clinical signs and EEG profiles in hypercalcemic encephalopathy Acta Neurologica Belgica 77(3): 129-143
Takenaka, T.; Tsukamura, M. 1970: A trial of treatment for pulmonary tuberculosis patients showing multiple resistance to anti-tuberculosis drugs. 1. a fundamental experiment of MIC of demethyl-chlortetracycline (LM) to M. tuberculosis and other mycobacteria Kekkaku: 45(3): 93-96
Kumar, R.; Ahirwar, R.K.; Dave, L.; Srivastava, N.; Bajpai, A.; Jain, S.; Gargava, A.; Vaish, S.K. 2018: Treatment Outcome and Efficacy of Anti-Tuberculosis Treatment in Tuberculosis Patients Put on Dots in Rntcp in Central India Journal of Evolution of Medical and Dental Sciences 7(15): 1840-1844
Chino, H.; Hagiwara, E.; Sekine, A.; Kitamura, H.; Baba, T.; Shinohara, T.; Komatsu, S.; Ogura, T. 2016: [compliance Rate of Standard Treatment Regimen and Optimal Dose of Anti-Tuberculosis Drugs in Late Elderly Patients with Pulmonary Tuberculosis Kekkaku: 91(5): 495-502
Pohl, C.; Jansen, B.; Peters, K.; Steinbrich, W.; Baldamus, C.A. 1989: Hypercalcemic crisis and multiple osteolyses in an elderly patient Medizinische Klinik 84(2): 90-97
Takeda, T.; Okada, A.; Unno, R.; Umemoto, Y.; Tozawa, K.; Yasui, T. 2016: A Case of Primary Hyperparathyroidism Complicated with Hypercalcemic Crisis during Treatment with Cinacalcet and Improved by Active Treatment Hinyokika Kiyo. Acta Urologica Japonica 62(12): 633-637
Pacheco, C.R.; Ramos, J.; Herrera, M.; Blancarte, L.; Jiménez, H. 1981: Short-term anti-tuberculosis treatment Gaceta Medica de Mexico 117(1): 35-39
Ohi, S.; Niimi, S.; Okada, N.; Yamada, K.; Tachibana, T.; Hashimoto, H.; Nakajima, M.; Yasuda, M.; Tanaka, T.; Sato, K.; Ishikawa, H. 2004: Establishment and characterization of a human ovarian small cell carcinoma, hypercalcemic type, cell line (OS-1) secreting PTH, PthrP and ACTH--special reference to the susceptibility of anti-cancer drugs Human Cell 17(4): 203-209
Moriya, K.; Kojima, H.; Matsumura, M.; Sakurai, S.; Imazu, H.; Uemura, M.; Honda, H.; Fukui, H. 2003: Disappearance of hepatic encephalopathy and improvement of liver function after surgical treatment of portal-systemic shunt in a patient with liver cirrhosis Hepato-Gastroenterology 50(52): 1128-1132
Rakotomanana, F.; Rabarijaona, L.P.; Ratsitorahina, M.; Cauchoix, B.; Razafinimanana, J.; Ratsirahonana, A.; Boisier, P.; Aurégan, G. 1999: Profile of the patients lost to treatment in the National Anti-Tuberculosis Program in Madagascar Sante 9(4): 225-229
Li, L.F.; Lin, M.C.; Chen, N.H.; Hsieh, M.J.; Lee, C.H.; Tsao, T.C. 1998: Serodiagnosis of tuberculosis by enzyme-linked immunosorbent assay for anti-A60 and anti-A38 Changgeng Yi Xue Za Zhi 21(3): 258-264
Kabedi, M.J.; Kashongwe, M.; Kayembe, J.M.; Mumba Ngoyi, D.; Mampasi, P.; Mbaya, P.; Fissette, K.; Verhaegen, J.; Portaels, F.; Muyembe-Tamfum, J.J. 2007: Primary resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Kinshasa, (DRC) Bulletin de la Societe de Pathologie Exotique 100(4): 275-276
Poletaev, S.D.; Flit, I.A.; Gurtovĭ, I.M.; Ianov, E.I.; Kusikova, L.M. 1978: Epidemiological and clinical changes in tuberculosis during the past 40 years (according to the data of the regional anti-tuberculosis dispensary) Problemy Tuberkuleza 10: 3-6
Khomenko, A.G. 1986: Objectives of anti-tuberculosis institutions in conducting general dispensarization of the population in the prevention of tuberculosis Problemy Tuberkuleza 1986(2): 6-10
Sunpath, H.; Winternheimer, P.; Cohen, S.; Tennant, I.; Chelin, N.; Gandhi, R.T.; Murphy, R.A. 2014: Double-dose lopinavir-ritonavir in combination with rifampicin-based anti-tuberculosis treatment in South Africa International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(6): 689-693
Michałowska-Mitczuk, D.; Gajda, W.; Kuś, J. 1997: Anti-expectorant treatment of patients with tuberculosis and diabetes, liver and renal failure, during pregnancy and breast-feeding Pneumonologia i Alergologia Polska 65(3-4): 270-277
Akbulut, Z.; Canda, A.E.; Atmaca, A.F.; Cimen, H.I.; Hasanoglu, C.; Balbay, M.D. 2010: BCG sepsis following inadvertent intravenous BCG administration for the treatment of bladder cancer can be effectively cured with anti-tuberculosis medications New Zealand Medical Journal 123(1325): 72-77
Luciak, K. 1982: Tuberculosis control within the administrative regions of an anti-tuberculosis clinic in Maków Mazowiecki in 1959-1974 Pneumonologia Polska 50(11): 589-597
Toyoara, M.; Iwasaki, T. 1971: Anti-tuberculosis activity of rifampicin for experimental tuberculosis of mice Kekkaku: 46(1): 19-22